We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Gyros Announces Availability of Protein A immunoassay Kit for Gyrolab xP Workstations
Product News

Gyros Announces Availability of Protein A immunoassay Kit for Gyrolab xP Workstations

Gyros Announces Availability of Protein A immunoassay Kit for Gyrolab xP Workstations
Product News

Gyros Announces Availability of Protein A immunoassay Kit for Gyrolab xP Workstations


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Gyros Announces Availability of Protein A immunoassay Kit for Gyrolab xP Workstations"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Two Host Cell Proteins (HCP) Kits are already available for detecting impurities from E.coli or CHO cells during bioprocess development and production.

Scientists optimizing purification processes and working in process control, routine QC and product release testing can now accelerate assay development timelines and maximize productivity through the convenience of three, ready-to-use kits and the automated immunoassay platform from Gyros.

Ken Hoffmann, President at Cygnus Technologies, explained: “At Cygnus we specialize in providing analytical products for testing biologics and their impurities. By continually adding to our range of kits compatible with this assay platform we will enable our customers to further increase the productivity of their labs.”

Commenting on the announcement, Erik Walldén, CEO at Gyros, added: “Biopharmaceutical companies and their service providers, CROs and CMOs, already use our platform to increase the efficiency of their workflows. For example, users of Gyrolab workstations have cut assay development times down to days compared to the weeks required for conventional techniques. Application-specific kits from independent suppliers strengthen our offering and demonstrate the acceptance of our nanoliter-scale immunoassay platform within the industry.”

Kits will be sold and supported through Cygnus Technologies.

Advertisement